Literature DB >> 11861212

Regulation of calcium release by interdomain interaction within ryanodine receptors.

Noriaki Ikemoto1, Takeshi Yamamoto.   

Abstract

In excitation-contraction (E-C) coupling, various types of activation signals, which are received presumably at the bulky cytoplasmic domain of the ryanodine receptor (RyR), are translated (or transduced) into the opening of the Ca2+ release channel located in the trans-membrane domain of the RyR. In order to elucidate the detailed mechanism of the signal transduction process, it is essential (i) to identify various sub-domains of the RyR that are involved in the Ca2+ channel regulation, (ii) to characterize the events occurring in these sub-domains during the activation process, and (iii) to characterize the modes of active interactions among these sub-domains. Recent developments in the E-C coupling research have provided us with new insight into each of these aspects, as outlined in this review. Of many putative regulatory sub-domains of the RyR, two domains (designated as N-terminal domain and central domain) are particularly interesting, because disease-linked mutations that have occurred in these domains (malignant hyperthermia and central core disease in skeletal muscle, and inheritable cardiac disease) induce abnormal modes of Ca2+ channel regulation. Pieces of evidence accumulated to this date suggest the following hypothesis. The N-terminal and central domains form, at least partly, the interacting domain pair, and unzipping and zipping actions of such domain-pair are involved in the opening and closing actions of the Ca2+ channel, respectively. We also propose that there are local conformational changes in the signal reception domains (e.g. the II-III loop-binding core), and such conformational changes are coupled with the aforementioned actions of the interacting domain pair. It seems that by virtue of such a coordination of the events occurring in various regions of the RyR, the Ca2+ channel can recognize the activation signal received at the cytoplasmic region of the RyR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861212     DOI: 10.2741/A803

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  49 in total

1.  Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus.

Authors:  Chun Hong Shao; Chengju Tian; Shouqiang Ouyang; Caronda J Moore; Fadhel Alomar; Ina Nemet; Alicia D'Souza; Ryoji Nagai; Shelby Kutty; George J Rozanski; Sasanka Ramanadham; Jaipaul Singh; Keshore R Bidasee
Journal:  Mol Pharmacol       Date:  2012-05-30       Impact factor: 4.436

Review 2.  Altered intracellular Ca2+ handling in heart failure.

Authors:  Masafumi Yano; Yasuhiro Ikeda; Masunori Matsuzaki
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

3.  Localization of a disease-associated mutation site in the three-dimensional structure of the cardiac muscle ryanodine receptor.

Authors:  Zheng Liu; Ruiwu Wang; Jing Zhang; S R Wayne Chen; Terence Wagenknecht
Journal:  J Biol Chem       Date:  2005-09-11       Impact factor: 5.157

4.  Localization of an NH(2)-terminal disease-causing mutation hot spot to the "clamp" region in the three-dimensional structure of the cardiac ryanodine receptor.

Authors:  Ruiwu Wang; Wenqian Chen; Shitian Cai; Jing Zhang; Jeff Bolstad; Terence Wagenknecht; Zheng Liu; S R Wayne Chen
Journal:  J Biol Chem       Date:  2007-04-23       Impact factor: 5.157

5.  The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule.

Authors:  Ching-Chieh Tung; Paolo A Lobo; Lynn Kimlicka; Filip Van Petegem
Journal:  Nature       Date:  2010-11-03       Impact factor: 49.962

6.  Interdomain cytoplasmic interactions govern the intracellular trafficking, gating, and modulation of the Kv2.1 channel.

Authors:  Durga P Mohapatra; Dominic F Siino; James S Trimmer
Journal:  J Neurosci       Date:  2008-05-07       Impact factor: 6.167

7.  CCDI: a new ligand that modulates mammalian type 1 ryanodine receptor (RyR1).

Authors:  Chengju Tian; Chun Hong Shao; Christina Padanilam; Edward Ezell; Jaipaul Singh; Shelby Kutty; Keshore R Bidasee
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

8.  Integrins protect cardiomyocytes from ischemia/reperfusion injury.

Authors:  Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

9.  Ligand-dependent conformational changes in the clamp region of the cardiac ryanodine receptor.

Authors:  Xixi Tian; Yingjie Liu; Ying Liu; Ruiwu Wang; Terence Wagenknecht; Zheng Liu; S R Wayne Chen
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

10.  N-terminal and central segments of the type 1 ryanodine receptor mediate its interaction with FK506-binding proteins.

Authors:  Tanya Girgenrath; Mohana Mahalingam; Bengt Svensson; Florentin R Nitu; Razvan L Cornea; James D Fessenden
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.